Fuse Medical, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a FZMD research report →
Price Chart
About the company
Headquartered in Richardson, Texas, Fuse Medical, Inc. operates as a U. S.
- CEO
- Christopher C. Reeg
- IPO
- 1999
- Employees
- 31
- HQ
- Farmers Branch, TX, US
Get TickerSpark's AI analysis on FZMD
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $1.85M
- P/E
- 12.50
- PEG
- 0.02
- P/S
- 0.20
- P/B
- 0.26
- EV/EBITDA
- 7.49
- Div Yield
- 0.00%
- Gross Margin
- 71.95%
- Op Margin
- 4.25%
- Net Margin
- 1.52%
- ROE
- 2.05%
- ROIC
- 3.75%
Latest fiscal year · YoY change
- Revenue
- $9.02M-15.9%
- Gross Profit
- $6.49M-5.5%
- Op Income
- $383.78K
- Net Income
- $136.91K-73.4%
- EPS
- $0.00-72.6%
- OCF Growth
- +216.4%
- FCF Growth
- +162.6%
- 52W High
- $0.08
- 52W Low
- $0.02
- 50D MA
- $0.02
- 200D MA
- $0.03
- Beta
- -0.45
- RSI (14)
- 48
- Avg Volume
- 8.58K
No earnings-call transcripts are available for FZMD yet.
- Free Float
- 14.3%
- Shares Outstanding
- 73.90M
- Float Shares
- 10.57M
Buy/sell ratio 3.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Dec 15, 22 | Reeg Christopher C | other | 333,333 |
| Dec 15, 22 | Yellin Lawrence Scott | other | 333,333 |
| Dec 15, 22 | Brooks Mark W | other | 333,333 |
| Nov 16, 22 | Brooks Mark W | other | 600,000 |
| May 25, 22 | Yellin Lawrence Scott | other | 0 |
| Dec 31, 21 | Reeg Christopher C | other | 0 |
| Dec 31, 21 | Reeg Christopher C | other | 0 |
| Nov 4, 21 | Reeg Christopher C | other | 73,530 |
| Dec 23, 21 | Brooks Mark W | other | 107,143 |
| Nov 4, 21 | Brooks Mark W | other | 73,530 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our FZMD coverage
Recent articles, reports, and earnings notes.
No research on FZMD yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate FZMD report →Golf Rounds.com (OTCMKTS:FZMD) Stock Price Crosses Above Fifty Day Moving Average – Here’s Why
defenseworld.net · Sep 25
Golf Rounds.com (OTCMKTS:FZMD) & Becton, Dickinson and Company (NYSE:BDX) Financial Survey
defenseworld.net · Dec 28
Fuse Medical, Inc. Announces Second Quarter 2023 Financial Results
globenewswire.com · Aug 15
Fuse Medical, Inc. Announces Official Launch of FuseChoice™ Dermal Matrix
businesswire.com · Sep 9
Fuse Medical, Inc. Announces Initial Launch of Orbitum™ Compression Staple System
businesswire.com · Aug 19
Fuse Medical, Inc. Announces First Quarter 2021 Financial Results
businesswire.com · Aug 12
Fuse Medical, Inc. Announces First Quarter 2021 Financial Results
businesswire.com · May 13
Fuse Medical, Inc. Announces Fiscal Year 2020 Financial Results
businesswire.com · Apr 2
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.